{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "51754-4200",
      "generic_name": "ephedrine sulfate",
      "labeler_name": "Exela Pharma Sciences, LLC",
      "brand_name": "Akovaz",
      "active_ingredients": [
        {
          "name": "EPHEDRINE SULFATE",
          "strength": "50 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "51754-4200-4",
          "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (51754-4200-4)  / 1 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20210415",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Exela Pharma Sciences, LLC"
        ],
        "rxcui": [
          "1116294",
          "1796730",
          "2586841",
          "2586845"
        ],
        "spl_set_id": [
          "e92f3eda-33eb-4b34-9e8b-db8d32a5dbd9"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "U6X61U5ZEG"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "INJECTION",
      "spl_id": "5a627a89-7997-4af5-a1d0-2cedbe1bc868",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20210415",
      "product_id": "51754-4200_5a627a89-7997-4af5-a1d0-2cedbe1bc868",
      "application_number": "NDA208289",
      "brand_name_base": "Akovaz",
      "pharm_class": [
        "Adrenergic alpha-Agonists [MoA]",
        "Adrenergic beta-Agonists [MoA]",
        "Increased Norepinephrine Activity [PE]",
        "Norepinephrine Releasing Agent [EPC]",
        "alpha-Adrenergic Agonist [EPC]",
        "beta-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}